Becton Dickinson (BDX) Cash & Current Investments (2009 - 2026)
Becton Dickinson's (BDX) quarterly Cash & Current Investments came in at $816.0 million in Q1 2026, up 9.24% year-on-year from $747.0 million in Q1 2025, and up 8.66% on a QoQ basis from $751.0 million in Q4 2025.
Becton Dickinson (BDX) Cash & Current Investments (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Cash & Current Investments data on file, last reported at $816.0 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 9.24% year-over-year to $816.0 million in Q1 2026; TTM through Mar 2026 was $816.0 million, a 9.24% increase from a year earlier, with the FY2025 full-year figure at $575.0 million, down 69.02% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $816.0 million, up from $751.0 million in the prior quarter.
- Over the last five years, Cash & Current Investments for BDX reached as high as $5.3 billion in Q2 2024 and fell as low as $575.0 million in Q3 2025.
- Historically, Cash & Current Investments has averaged $1.6 billion across 5 years, with a median of $1.2 billion in 2022.
- Across the five-year window, Cash & Current Investments jumped 418.55% in 2024 and slumped 84.99% in 2025, its largest moves.
- Year by year, Cash & Current Investments stood at $612.0 million in 2022, then jumped by 93.14% to $1.2 billion in 2023, then tumbled by 38.41% to $728.0 million in 2024, then grew by 3.16% to $751.0 million in 2025, then advanced by 8.66% to $816.0 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $816.0 million in Q1 2026, $751.0 million in Q4 2025, and $575.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.62 Bn | 121.41 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 44.86 Bn | 44.04 Bn | 2.15 Bn | 816.00 Mn |
| 3 | Alcon | 33.17 Bn | 31.51 Bn | 1.53 Bn | 1.66 Bn |
| 4 | Medline | 32.89 Bn | 30.65 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 23.19 Bn | 22.76 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 14.08 Bn | 13.52 Bn | 1.10 Bn | 561.00 Mn |
| 8 | Cooper Companies | 13.85 Bn | 13.71 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Align Technology | 12.14 Bn | 11.08 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Baxter International | 11.94 Bn | 9.92 Bn | 891.00 Mn | 2.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 816.00 Mn |
| Dec 31, 2025 | 751.00 Mn |
| Sep 30, 2025 | 575.00 Mn |
| Jun 30, 2025 | 797.00 Mn |
| Mar 31, 2025 | 747.00 Mn |
| Dec 31, 2024 | 728.00 Mn |
| Sep 30, 2024 | 1.86 Bn |
| Jun 30, 2024 | 5.31 Bn |
| Mar 31, 2024 | 2.39 Bn |
| Dec 31, 2023 | 1.18 Bn |
| Sep 30, 2023 | 1.48 Bn |
| Jun 30, 2023 | 1.02 Bn |
| Mar 31, 2023 | 1.99 Bn |
| Dec 31, 2022 | 612.00 Mn |
| Sep 30, 2022 | 1.16 Bn |
| Jun 30, 2022 | 2.76 Bn |
| Mar 31, 2022 | 3.32 Bn |
| Dec 31, 2021 | 2.05 Bn |
| Sep 30, 2021 | 2.39 Bn |
| Jun 30, 2021 | 3.18 Bn |